UPDATE 1-Tonix Pharma's pain drug fails mid-stage study
September 29, 2014 at 07:45 AM EDT
Sept 29 (Reuters) - Tonix Pharmaceuticals Holding Corp said its lead pain drug failed the main goal of a mid-stage study, sending its shares down by nearly half in premarket trading.
